期刊文献+

猪链球菌2型溶血素的纯化及生物学活性研究 被引量:4

Purification and biological activities analysis of Streptococcus suis Serotype 2 suilysin
下载PDF
导出
摘要 目的:摸索天然和重组猪链球菌2型溶血素的纯化工艺,评价制备蛋白的生物学活性。方法:天然猪溶血素的纯化采用硫酸铵沉淀,阴离子交换层析和疏水层析制备,重组猪溶血素采用镍柱亲和层析进行柱上变复性后,用Th iolproyl-sepharose 6B进一步亲和纯化。通过溶血实验,细胞毒性测定实验评价纯化蛋白的活性。结果:制备的天然和重组猪溶血素纯度均在90%以上,具有较高的溶血活性,较高浓度时能损伤靶细胞,胆固醇能够完全封闭其活性。结论:制备获得的重组猪溶素与天然蛋白具有相近的生物学活性,为进一步研究猪链球菌2型溶血素在猪链球菌致病机制方面的作用奠定了基础。 AIM:To explore the purification methods of wild-type and recombinant suilysin and to evaluate their biological activities.METHODS: Wild-type suilysin was purified by ammonium sulfate precipitation,anion-exchange chromatography and hydrophobic chromatography in turn,while recombinant suilysin was first refolded and purified by immobilized metal ion affinity chromatography,and further purified by Thiopropyl Sepharose 6B.The biological activities were evaluated by hemolysis test,cytotoxicity assay.RESULTS: Both prepared wild-type and recombinant suilysin,with purify over 90%,have hemolysis activity and could injure target cells at high concentration while cholesterol could completely inhibit their activities.CONCLUSION: Recombinant suilysin has similar biological activities with wild-type suilysin,and this work contributed to further study the functions of suilysin on pathogenesis of steptococcus suis.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2011年第4期374-376,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金资助项目(30870091)
关键词 猪链球菌2型 猪链球菌溶血素 溶血活性 细胞毒性 Streptococcus suis serotype 2 suilysin hemolysis activity cytotoxicity
  • 相关文献

参考文献2

二级参考文献7

  • 1徐俊杰,张军,刘树玲,吕天敬,陈薇,李冠霖,葛猛,郭强.针对炭疽保护性抗原不同结构域的中和性单克隆抗体的筛选和鉴定[J].微生物学报,2005,45(6):947-951. 被引量:4
  • 2李冰,李建民,徐俊杰,刘树玲,张羽,付玲,陈薇.抗炭疽保护性抗原单克隆抗体可变区基因的克隆及序列分析[J].生物技术通讯,2007,18(2):179-182. 被引量:5
  • 3Subramanian GM, Cronin PW, Poley G, et al. A phase 1 study of PAmAb, a fully human monoclonal antibody against bacillus anthracis protective antigen, in healthy volunteers[ J]. Clinical Infectious Diseases, 2005, 41(1) : 12 -20.
  • 4Laura V, Diann B, Israel L, et al. Prophylaxis and therapy of inhala- tional anthrax by a novel monoelonal antibody to protective antigen that mimics vaccine-induced immunity [ J ]. Infect Immunity, 2006, 74 (10) : 5840 -5847.
  • 5Peterson JW, Comer JE, Baze WB, et al. Human monoclonal antibody AVP-21 D9 to protective antigen reduces dissemination of the bacillus anthracis Ames strain from the lungs in a rabbit model[ J]. Infect Immunity, 2007, 75(7) : 3414 -3424.
  • 6Li BH, Wang H, Dai JX, et al. Construction and characterization of a humanized anti-human CD3 monoclonal antibody 12F6 with effective immunoregulation functions[ J]. Immunology, 2005, 116(2) : 487 - 498.
  • 7Hu WG, Chau D, Wu J, et al. Humanization and mammalian expression of a murine monoclonal antibody against Venezuelan equine encephalitis virus[J]. Vaccine, 2007, 25(16): 3210-3214.

共引文献9

同被引文献20

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部